Disc Medicine Prices Upsized $450 Million Stock Offering at $75 a Share

By Public Technologies
  • Disc Medicine priced an upsized public offering of common stock expected to raise $450 million in gross proceeds before expenses.
  • The offering comprises 6,000,000 shares at $75 per share.
  • Underwriters have a 30-day option to purchase up to 900,000 additional shares at the offering price, less underwriting discounts and commissions.
  • Closing is expected on October 22, 2026, subject to customary conditions.
  • Net proceeds will support clinical development, potential bitopertin commercialization for EPP and XLP, other pre-commercialization activities and general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610202052PRIMZONEFULLFEED9850027) on October 21, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk